Many stocks are objectively overvalued. That can make it difficult for investors to find opportunities for stocks with the potential to double. Penny stocks (i.e., stocks trading below $5) are among the usual suspects. However, these stocks have a risk-reward profile that is often only appropriate for risk-tolerant, nimble investors.
But there are always opportunities. One way to find them is to look at analyst sentiment. To be clear, analysts don’t always get it right. Nevertheless, they frequently have access to data and company resources that retail investors do not. That means it’s important to consider their opinion when conducting due diligence on a stock.
With that in mind, here are three stocks currently trading for less than $50 per share with significant upside potential. While analysts aren’t necessarily calling for them to double, the consensus price targets are close enough that each could be a double if the economy grows as expected.
Equinox Gold: Gold’s Momentum Could Keep Running
Equinox Gold Corp. (NYSEAMERICAN: EQX) is a Canadian gold mining company. As of Oct. 27, EQX stock is already up 100% for the year. However, analysts give the stock a consensus price target of $26, which is a gain of over 149% from its current level.
Of course, Equinox is a play on the surge in gold prices. Many analysts believe that mining stocks such as EQX are the best way for equity investors to capitalize on this surge in gold prices. The most bullish analysts believe the spot price of gold could reach $5,000 before the end of 2025, with even higher prices to follow in 2026.
Higher spot prices make Equinox’s mining operations profitable. The risk is that the gold trade could unwind. However, here’s something to consider. Institutional investor interest in EQX stock is only 38%, but it has been climbing sharply in the last 12 months and has been rising for over two years.
Birkenstock: A Consumer Stock Ready to Rebound
It’s been a challenging year for consumer discretionary stocks such as Birkenstock Group AG (NYSE: BIRK). BIRK stock is down 25% in 2025; however, it seems like the company is being lumped into a struggling retail sector without considering its apparent strong positioning.
Birkenstock’s year-over-year revenue and earnings are both higher, with revenue growth up double digits in all segments and channels. Plus, over the next 12 months, analysts project earnings growth of over 26%. That aligns nicely with the company’s forward price-to-earnings (P/E) ratio of around 23x.
What may also be attractive to investors is that BIRK stock carries a short interest of around 17%. That’s down in the last month, which could be positive for two reasons. First, it could mean that short sellers are losing their grip on the stock. Second, it still leaves room for a possible short squeeze if the stock bounces sharply.
Analysts give BIRK stock a consensus price target of $68.38, implying a potential gain of about 58%. The company reports third-quarter earnings on Dec. 17, and strong holiday sales could help drive the stock higher as it heads into 2026.
Biotechnology stocks are frequently targeted for their potential to double. The premise is that many of these companies are still in the clinical stage, making it a numbers game. If they can get one drug through the trial process and into the market, the company’s stock could rocket higher.
That’s the case with Immunocore, which is now generating measurable revenue and may be on the path to profitability. Analysts give IMCR stock a consensus price target of $61. However, HC Wainwright reiterated its Buy rating on the stock on Oct. 22 and assigned a price target of $100.
Not all analysts share that enthusiasm. Weiss analysts give the stock a Sell rating, reflecting a belief that all of the growth with the stock is priced in.
There’s a little-known market force that’s been quietly pushing certain stocks higher at the same time every year — for decades. It’s shown remarkable consistency across names like KO, WMT, and WFC, giving traders who know how to spot it a repeatable edge. I recently broke down how this pattern works, the key chart data behind it, and how to position for the next potential move.
While 2025 has seen a plethora of stocks post explosive gains, several high-flyers just got a bit of a wake-up call. Below, we’ll detail three stocks that have been among the most impressive in the market that have just taken big haircuts. Shifting national defense priorities, evolving telecommunication technology, and artificial intelligence (AI) data centers are among their key drivers.
Could these names be in store for a rebound, or might they keep trending in the wrong direction? Using Wall Street price target data, we’ll try to answer these questions below.
Analysts Slant Toward Reserved Recovery in MP Materials
First up is a company that few would have picked to be up more than 500% at one point in 2025; MP Materials (NYSE: MP). The stock exploded by 51% on July 10, as the U.S. Department of Defense announced an investment in the firm. MP is the United States’ only significant producer of rare-earth magnets, critical space and defense technology materials. The Trump administration is looking to strengthen the country’s rare-earth position as China works to restrict access to these resources. MP Materials shares eventually rose to just under $99, doubling after the July 10 spike. However, they have crashed by around 28% since that high to just under $71.
After this drop, the MarketBeat consensus price target on MP of $77.80 implies around 10% upside potential. Still, the range of forecasts is pretty broad. Analysts at JPMorgan Chase & Co. project shares will go to $64, representing an additional downside of nearly 10%. The stock also holds several $69 targets, implying slight downside. Meanwhile, Bank of America’s lofty $112 target suggests that the stock will surge past previous highs, generating upside of nearly 58%.
Analysts seem to be leaning toward a measured recovery in MP shares.
Wall Street on AST SpaceMobile: The Correction Could Compound
AST SpaceMobile (NASDAQ: ASTS) has indisputably been one of the most significant standout stocks of 2025. The firm is working to deploy its low-earth-orbit (LEO) satellites to provide mobile internet coverage to every corner of the planet. In mid-October, shares closed at their highest level of just under $96, putting the stock up more than 350% in 2025. However, things have taken a big step in the wrong direction. On Oct. 24, AST SpaceMobile closed at just under $74, marking a steep 23% drop from its highs.
The rise and fall of the stock are both driven by understandable reasons.
The company has entered commercial agreements with some of the world’s largest telecom companies, like AT&T (NYSE: T) and Verizon Communications (NYSE: VZ), providing a huge potential customer base. However, the stock was also valued at nearly $35 billion while generating less than $5 million in revenue in the last 12 months.
Analysts still see substantial room for shares to fall. The MarketBeat consensus price target of just over $45 implies nearly 39% downside potential. Additionally, ASTS’s most bullish recent target of $60 implies almost 19% downside. Analysts view AST SpaceMobile shares as overvalued, even after their precipitous decline.
ALAB May Be in Store for +25% Recovery After Massive Drop
Last up is Astera Labs (NASDAQ: ALAB). This company has become prominent due to its relationship with the almighty NVIDIA (NASDAQ: NVDA). Specifically, the firm has been selling its retimers with NVIDIA’s Blackwell servers. Retimers reamplify degraded data signals, allowing data to travel reliably between distant server components. In 2025, shares closed at nearly $252 through mid-September, marking a 90% gain.
However, Astera Labs has taken an enormous tumble, falling to approximately $165, down nearly 35% from its high.
The MarketBeat-tracked consensus price target of around $162 implies a 2% downside in shares. However, the majority of recent targets are far more optimistic. For example, among forecasts updated since the beginning of September, the average target is just over $207. This figure implies around 26% upside potential. Additionally, the most bearish recent target of $155 implies only around 6% downside. In contrast, the most recent bullish target of $230 means a 39% upside.
Analysts Eye ALAB Recovery, ASTS Could See Further Weakness
Among these three stocks, analysts evidently have the most faith in Astera Labs’ ability to rebound.
Meanwhile, analysts appear solidly mixed on MP Materials, with a moderate bent to the upside. On the other hand, their outlook on AST SpaceMobile is decidedly negative at this point.
People spend 30 hours a week on their smartphones. And Mode has unlocked 19 ways to profit from it.
Deloitte called them the #1 fastest-growing software company in North America in 2023 — and accredited investors can still get in while the opportunity remains open.
This year, the market’s seen its fair share of so-called Trump trades. Over the past quarter specifically, the president has announced that the government will be taking equity stakes in at least three publicly traded companies. As a result, those deals have sent their respective stocks skyrocketing.
Last week, after rumors that the administration was considering another, it’s evident that investors should expect these deals—the aim of which is to shore up domestic supply chains as a matter of national security—to continue.
The next target the president may have his sights set on? Quantum computing.
The Trump Administration’s Evolving Track Record of Equity Stakes
One of the first companies to benefit from President Trump’s interest in taking equity stakes was MP Materials (NYSE: MP). As a vertically-integrated producer of rare Earth elements (REEs), MP Materials owns and manages Mountain Pass Rare Earth Mine and Processing Facility in California—the only commercially viable REE site in the United States.
On July 10, the company signed a deal with the government which took a 15% stake in MP Materials in exchange for the U.S. Department of Defense investing $400 million in preferred stock, making it MP Materials’ largest shareholder. Since then, the stock is up nearly 136%.
Next, in August, the administration took a 10% equity stake in legacy digital technology firm Intel Corporation (NASDAQ: INTC). That deal was valued at $8.9 billion upon its announcement. Since Aug. 1, shares of the formerly struggling INTC are up more than 98%.
Then in late September, the administration announced that it was taking a 5% equity stake in pre-revenue Lithium Americas (NYSE: LAC)—a Vancouver-based mining company—and another 5% equity stake in the Thacker Pass venture that it jointly owns alongside General Motors (NYSE: GM).
The Thacker Pass project represents the largest lithium reserves in the United States, one of the largest in the world and its stockpile is expected to satisfy 25% of global demand for the metal, which is essential to the ongoing EV revolution.
The mine isn’t expected to be fully operational until 2027. Nonetheless, in the wake of that announcement, shares of LAC—a company that posted -$43 million in net income last year to go along with $100 million in total liabilities—surged more than 227% from Sept. 23 to Oct. 14.
Is Quantum Computing Trump’s Newest Equity Target?
After announcing deals with MP Materials, Intel, and Lithium Americas in less than three months, the administration is signaling that it’s willing to invest significant capital to ensure the sustained success of what it views as mission-critical organizations.
Last Thursday, the Wall Street Journal reported that, according to a source in the Department of Commerce, the administration was considering several new equity deals, this time with a handful of quantum computing companies.
Shares of those four firms gapped up at Thursday’s open, gaining 8.08%, 9.47%, 11.34%, 23.31%, and 8.08%, respectively, since. However, by Thursday afternoon, the Trump administration tamped down expectations, telling CNBCthat it was not “currently” in negotiations with quantum computing companies.
A Boon for an Industry That Is Still in Its Infancy
Despite the administration’s claim that it wasn’t presently engaged in negotiations with quantum firms, that market corner continued rallying through Friday’s close.
However, like the Lithium Americas deal, any prospective deal with the aforementioned quantum computing companies would still take years to bear fruit. According to McKinsey & Co., “surging investment and faster-than-expected innovation could propel the quantum market to $100 billion in a decade.”
But a decade is a long time to wait for any single speculative stock to take the next step forward. Despite Big Tech’s best efforts to accelerate practical applications, only small-scale quantum computers currently exist, and their uses are limited to prototypes and hands-on experimentation with quantum principles.
Instead, patient buy-and-hold investors can gain exposure with the world’s largest quantum-themed ETF: the Defiance Quantum ETF (NASDAQ: QTUM). With $2.95 billion in net assets, the fund’s 0.40% expense ratio is offset by a dividend yielding 0.66%, or 73 cents per share annually.
Last week’s rally sent the ETF nearly 5% higher. Over the past 12 months, institutional investors have poured $38.66 million into QTUM while the fund has only seen $2.69 million in outflows. Current short interest is just 1.92%.
As power outages become more common, and the need for clean, resilient energy rises, Paladin’s solution offers more than just a backup – it offers peace of mind. Over 3,000 investors have already contributed more than $9.2M to this movement.
The Night Owl is a financial newsletter that provides in-depth market analysis on stocks of interest to individual investors. Published by MarketBeat and Early Bird Publishing, The Night Owl is delivered around 9:00 PM Eastern Sunday through Thursday. If you give a hoot about the market, The Night Owl is the newsletter for you.